|
|
|
| Explore the forefront of precision medicine at the Advancing Precision Medicine Conference and Exhibition in Philadelphia, November 1-2. Engage with cutting-edge research featuring experts who are shaping the future of healthcare. Discover new insights into personalized treatments, genomic advancements, and innovative technologies revolutionizing patient care. Expand your knowledge and network with leaders driving the field forward. View the agenda and register today! |
|
|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | As I argued in a previous “Hot Take,” “the devil is in the details” when it comes to developing both our drug substances and our drug products. We need to get to the point where we have more details and knowledge about alternative methods of delivery (beyond LNPs) so we can make educated decisions on the best path forward for delivering our products. |
|
|
|
Explore genetic regulation, synthetic biology's role in genetically programming mRNA to deliver therapies, and how Strand Therapeutics is enabling precise and controlled delivery with these mRNA constructs. |
|
|
|
By Eric Doerr, Sanofi, Toronto | Balancing stakeholder expectations and opinions, and sometimes mitigating disagreements, during a change can prove more daunting than the change itself. |
|
|
|
The Advancing RNA Live panelists share several inconsistencies they’ve encountered working with global regulators, as well as on which aspects they’re seeing regulatory agencies applying greater scrutiny in mRNA development today. |
|
|
|
|
|
|
| A New Centre For Continuous mRNA Manufacturing | Article | ReciBioPharm | Explore how a partnership between academia, regulatory agencies, and manufacturing organizations has the potential to reshape the way we produce and distribute mRNA-based therapies. |
|
|
| Effects Of mRNA Capping Technologies | Poster | By Christian Cobaugh, Kurtis Breger, et al., Vernal Biosciences | This study compares two important mRNA capping technologies by evaluating the mRNA integrity, percent Cap1 content, dsRNA content, in vivo expression, and innate immune activation in mice. |
|
|
|
.png){kind=logo}
